X-ZELL Cryoimmunostaining™ technology live in Europe Brussels, February 2020 – Following the official European launch of X-ZELL Cryoimmunostaining™ in November 2019, the Singapore start-up will be holding a series of Live Sessions in 2020 in order to introduce the new...
Episode 14 Inside Europe’s push for early cancer detection Overshadowed by the world’s ongoing battle with the Wuhan coronavirus, the European Commission (EC) announced last week that it is getting serious about early cancer detection. On the back of a bold commitment...
X-ZELL selected as Finalist for 2020 Hello Tomorrow Global Challenge Singapore, January 2020 – Singapore med tech start-up, X-ZELL, has been nominated as a Global Finalist for the 2020 Hello Tomorrow Challenge. Considered one of the world’s leading deep tech start-up...
X-ZELL named Deep Tech Pioneer by Hello Tomorrow Singapore, November 2019 – On the back of qualifying for the regional final of the prestigious Hello Tomorrow Challenge, X-ZELL has now been selected as one of Hello Tomorrow’s Deep Tech Pioneers. According to the...
Episode 13 Navigating medical start-up vocabulary “X-ZELL fuses next-generation rare cell detection technology with Artificial Intelligence to catapult pathology into the digital age. The result is an accurate, affordable and scientifically proven method of screening...
